The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
Open accessAbstract
Galectin-3 is a member of the galectin family, which are β‑galactoside‑binding lectins with ≥1 evolutionary conserved carbohydrate‑recognition domain. It binds proteins in a carbohydrate‑dependent and ‑independent manner. Galectin‑3 is predominantly located in the cytoplasm; however, it shuttles into the nucleus and is secreted onto the cell surface and into biological fluids including serum and urine. It serves important functions in numerous biological activities including cell growth, apoptosis, pre‑mRNA splicing, differentiation, transformation, angiogenesis, inflammation, fibrosis and host defense. Numerous previous studies have indicated that galectin‑3 may be used as a diagnostic or prognostic biomarker for certain types of heart disease, kidney disease and cancer. With emerging evidence to support the function and application of galectin‑3, the current review aims to summarize the latest literature regarding the biomarker characteristics and potential therapeutic application of galectin‑3 in associated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., Zamora, E., Urrutia, A., & Lupón, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.087 · Cited by 259
Galectin 3 as a guardian of the tumor microenvironment
Ruvolo, P. P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.08.008 · Cited by 224
van der Velde, A. R., Gullestad, L., Ueland, T., Aukrust, P., Guo, Y., Adourian, A., Muntendam, P., van Veldhuisen, D. J., & de Boer, R. A. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000129 · Cited by 216
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Calvier, L., Martinez-Martinez, E., Miana, M., Cachofeiro, V., Rousseau, E., Sádaba, J. R., Zannad, F., Rossignol, P., & López-Andrés, N. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.08.002 · Cited by 215
Galectin-3 in angiogenesis and metastasis
Funasaka, T., Raz, A., & Nangia-Makker, P. (2014) · Glycobiology · doi:10.1093/glycob/cwu086 · Cited by 211
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 208
Galectin-3 in autoimmunity and autoimmune diseases
de Oliveira, F. L., Gatto, M., Bassi, N., Luisetto, R., Ghirardello, A., Punzi, L., & Doria, A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215593826 · Cited by 203
Delaine, T., Collins, P., MacKinnon, A., Sharma, G., Stegmayr, J., Rajput, V. K., Mandal, S., Cumpstey, I., Larumbe, A., Salameh, B. A., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600285 · Cited by 199
Barrow, H., Guo, X., Wandall, H. H., Pedersen, J. W., Fu, B., Zhao, Q., Chen, C., Rhodes, J. M., & Yu, L.-G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1462 · Cited by 181
Edelmann, F., Holzendorf, V., Wachter, R., Nolte, K., Schmidt, A. G., Kraigher-Krainer, E., Duvinage, A., Unkelbach, I., Düngen, H.-D., Tschöpe, C., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.203 · Cited by 176
Harrison, S. A., Marri, S. R., Chalasani, N., Kohli, R., Aronstein, W., Thompson, G. A., Irish, W., Miles, M. V., Xanthakos, S. A., Lawitz, E., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13816 · Cited by 176
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
Gong, H. C., Honjo, Y., Nangia‐Makker, P., Hogan, V. A., Mazurak, N., Bresalier, R. S., & Raz, A. (1999) · PubMed · Cited by 175
Elevated Galectin-3 Precedes the Development of CKD
O’Seaghdha, C. M., Hwang, S.-J., Ho, J. E., Vasan, R. S., Levy, D., & Fox, C. S. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090909 · Cited by 170
Embryonic implantation in galectin 1/galectin 3 double mutant mice
Colnot, C., Fowlis, D., Ripoche, M.-A., Bouchaert, I., & Poirier, F. (1998) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199804)211:4<306::aid-aja2>3.0.co;2-l · Cited by 166
Anand, I. S., Rector, T. S., Kuskowski, M., Adourian, A., Muntendam, P., & Cohn, J. N. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs205 · Cited by 164
Menon, R. P., & Hughes, R. C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00671.x · Cited by 163
Meijers, W. C., Januzzi, J. L., deFilippi, C., Adourian, A. S., Shah, S. J., van Veldhuisen, D. J., & de Boer, R. A. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.011 · Cited by 158
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies
Drechsler, C., Delgado, G., Wanner, C., Blouin, K., Pilz, S., Tomaschitz, A., Kleber, M. E., Dressel, A., Willmes, C., Krane, V., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010093 · Cited by 149
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
MacKinnon, A. C., Liu, X., Hadoke, P. W. F., Miller, M. R., Newby, D. E., & Sethi, T. (2013) · Glycobiology · doi:10.1093/glycob/cwt006 · Cited by 148
Wu, A. H. B., Wians, F. H., & Jaffe, A. S. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.029 · Cited by 142
Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
Takemoto, Y., Ramírez, R. J., Yokokawa, M., Kaur, K., Ponce‐Balbuena, D., Sinno, M., Willis, B. C., Ghanbari, H., Ennis, S. R., Guerrero‐Serna, G., et al. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.003 · Cited by 139
Vergaro, G., Prudhomme, M., Fazal, L., Merval, R., Passino, C., Emdin, M., Samuel, J., Solal, A. C., & Delcayre, C. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06161 · Cited by 133
The Role of Galectin-3 in the Kidneys
Chen, S., & Kuo, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040565 · Cited by 133
Maiolino, G., Rossitto, G., Pedon, L., Cesari, M., Frigo, A. C., Azzolini, M., Plebani, M., & Rossi, G. P. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304964 · Cited by 123
Motiwala, S. R., Szymonifka, J. D., Belcher, A. M., Weiner, R. B., Baggish, A. L., Sluss, P. M., Gaggin, H. K., Bhardwaj, A., & Januzzi, J. L. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft075 · Cited by 120
Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction
Weir, R. A. P., Petrie, C. J., Murphy, C. A., Clements, S. E., Steedman, T., Miller, A. M., McInnes, I. B., Squire, I. B., Ng, L. L., Dargie, H. J., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000146 · Cited by 105
Up-Regulation of Galectin-3 in Acute Renal Failure of the Rat
Nishiyama, J., Kobayashi, S., Ishida, A., Nakabayashi, I., Tajima, O., Miura, S., Katayama, M., & Nogami, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64595-6 · Cited by 104
Guha, P., Kaptan, E., Bandyopadhyaya, G., Kaczanowska, S., Dávila, E., Thompson, K. N., Martin, S. S., Kalvakolanu, D. V., Vasta, G. R., & Ahmed, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202653110 · Cited by 98
Galectin-3 and post-myocardial infarction cardiac remodeling
Meijers, W. C., van der Velde, A. R., Pascual-Figal, D. A., & de Boer, R. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.025 · Cited by 95
The pleiotropic effects of galectin-3 in neuroinflammation: A review
Shin, T. (2013) · Acta Histochemica · doi:10.1016/j.acthis.2012.11.010 · Cited by 94
Tsai, T., Sung, P., Chang, L., Sun, C., Yeh, K., Chung, S., Chua, S. O., Chen, Y., Wu, C., Chang, H.-W., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12856 · Cited by 93
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension
Calvier, L., Legchenko, E., Grimm, L., Sallmon, H., Hatch, A., Plouffe, B. D., Schroeder, C., Bauersachs, J. K., Murthy, S. K., & Hansmann, G. (2016) · Heart · doi:10.1136/heartjnl-2015-308365 · Cited by 91
Prognostic value of serum galectin-3 in patients with heart failure: A meta-analysis
Chen, A., Hou, W., Zhang, Y., Chen, Y., & He, B. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.137 · Cited by 88
Schindler, E. I., Szymanski, J. J., Hock, K. G., Geltman, E. M., & Scott, M. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.246553 · Cited by 87
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy
Vergaro, G., Franco, A. D., Giannoni, A., Prontera, C., Ripoli, A., Barison, A., Masci, P. G., Aquaro, G. D., Solal, A. C., Padeletti, L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.008 · Cited by 85
Zhang, L., Wang, P., Qin, Y., Cong, Q., Shao, C., Du, Z., Ni, X., Li, P., & Ding, K. (2016) · Oncogene · doi:10.1038/onc.2016.306 · Cited by 85
Galectin-3 in diabetic patients
Pugliese, G., Iacobini, C., Ricci, P. C., Fantauzzi, C. B., & Menini, S. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0187 · Cited by 83
Galectin-3 in Heart Failure With Preserved Ejection Fraction
AbouEzzeddine, O. F., Haines, P., Stevens, S. R., Nativi-Nicolau, J. N., Felker, G. M., Borlaug, B. A., Chen, H. H., Tracy, R. P., D, E. B. M., & Redfield, M. M. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.10.009 · Cited by 82
Tuñón, J., Blanco‐Colio, L. M., Cristóbal, C., Tarín, N., Higueras, J., Huelmos, A. I., Alonso, J. J., Egido, J., Asensio, D., Lorenzo, Ó., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.012 · Cited by 81
Rajput, V. K., MacKinnon, A. C., Mandal, S., Collins, P. M., Blanchard, H., Leffler, H., Sethi, T., Schambye, H. T., Mukhopadhyay, B., & Nilsson, U. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00957 · Cited by 77
Role for Galectin‐3 in Calcific Aortic Valve Stenosis
Sádaba, R., Martínez‐Martínez, E., Arrieta, V., Álvarez, V., Fernández‐Celis, A., Ibarrola, J., Melero, A., Rossignol, P., Cachofeiro, V., & López‐Andrés, N. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004360 · Cited by 76
Role of galectin-3 in autoimmune and non-autoimmune nephropathies
Saccon, F., Gatto, M., Ghirardello, A., Iaccarino, L., Punzi, L., & Doria, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.023 · Cited by 74
Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels
Gürses, K. M., Yalçın, M. U., Koçyiğit, D., Canpınar, H., Evranos, B., Yorgun, H., ŞAHINER, L., Kaya, E. B., Ozer, N., Tokgözoğlu, L. S., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.12.021 · Cited by 73
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Jiang, S.-S., Weng, D., Wang, Q.-J., Pan, K., Zhang, Y., Li, Y.-Q., Li, X. H., Zhao, J.-J., He, J., Lv, L., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0273-3 · Cited by 72
Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Zhang, H., Liang, X., Duan, C., Liu, C., & Zhao, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103482 · Cited by 70
Focus on Molecules: Galectin-3
Argüeso, P., & Panjwani, N. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.11.009 · Cited by 68
Renal function largely influences Galectin-3 prognostic value in heart failure
Zamora, E., Lupón, J., de Antonio, M., Galán, A., Domingo, M., Urrútia, A., Troya, M. I., & Bayés‐Genís, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.011 · Cited by 67
Yang, Y., Zhou, Z., He, S., Fan, T., Jin, Y., Zhu, X. D., Chen, C., Zhang, Z., & Huang, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.007 · Cited by 65
Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
Clémenty, N., Benhenda, N., Piver, É., Pierre, B., Bernard, A. B., Fauchier, L., Pagès, J., & Babuty, D. (2016) · Scientific Reports · doi:10.1038/srep34357 · Cited by 64
Galectin-3: a possible complementary marker to the PSA blood test
Balan, V., Wang, Y., Nangia‐Makker, P., Kho, D., Bajaj, M., Smith, D. W., Heilbrun, L. K., Raz, A., & Heath, E. I. (2013) · Oncotarget · doi:10.18632/oncotarget.923 · Cited by 60
Wu, X., Li, S., Wen, S., Nie, J., Deng, W., Bai, R., Liu, N., Tang, R., Zhang, T., Du, X., et al. (2015) · EP Europace · doi:10.1093/europace/euv045 · Cited by 59
Predictive value of plasma galectin-3 in patients with chronic heart failure.
Chen, K., Jiang, R.-J., Wang, C.-Q., Yin, Z.-F., Fan, Y.-Q., Cao, J.-T., Han, Z.-H., Wang, Y., & Song, D.-Q. (2013) · PubMed · Cited by 59
Lepojärvi, E. S., Piira, O.-P., Pääkkö, E. L., Lammentausta, E., Risteli, J., Miettinen, J. A., Perkiömäki, J. S., Huikuri, H. V., & Junttila, J. M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00200 · Cited by 55
Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
Kornej, J., Schmidl, J., Ueberham, L., John, S., Daneschnejad, S. S., Dinov, B., Hindricks, G., Adams, V., Husser, D., & Bollmann, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123574 · Cited by 55
Ablation of galectin-3 induces p27KIP1-dependent premature senescence without oncogenic stress
Kim, S.-J., Lee, H. W., Kang, H., La, S.-H., Choi, I. J., Ro, J. Y., Bresalier, R. S., Song, J., & Chun, K.-H. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.88 · Cited by 54
Szadkowska, I., Wlazeł, R. N., Migała, M., Szadkowski, K., Zielińska, M., Paradowski, M. T., & Pawlicki, L. (2013) · Cardiology Journal · doi:10.5603/cj.2013.0157 · Cited by 53
Clinical significance of Galectin-3 in clear cell renal cell carcinoma
Sakaki, M., Fukumori, T., Fukawa, T., Elsamman, E., Avirmed, S., Nakatsuji, H., & Kanayama, H. (2010) · The Journal of Medical Investigation · doi:10.2152/jmi.57.152 · Cited by 53
Galectin-3: A key player in arthritis
Hu, Y., Yelehe‐Okouma, M., Ea, H., et al. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.02.029 · Cited by 53
Yan, X.-J., Yu, G., Jie, Y., Fan, X., Huang, Q., & Dai, W.-M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.071 · Cited by 51
Aggarwal, S., Sharma, S. C., & Das, S. N. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.038 · Cited by 50
Paunovic, I. R., Denčić, T. I., Havelka, M., Tatic, S. B., Cvejic, D. S., & Savin, S. B. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02842.x · Cited by 48
Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community
Nayor, M. G., Wang, N., Larson, M. G., Vasan, R. S., Levy, D. A., & Ho, J. E. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002347 · Cited by 48
Serum Galectin-3 as a Potential Marker for Gastric Cancer
Li, Y. (2015) · Medical Science Monitor · doi:10.12659/msm.892386 · Cited by 46
Galectin-3, Carotid Plaque Vulnerability, and Potential Effects of Statin Therapy
Kadoglou, N. P. E., Sfyroeras, G. S., Spathis, A., Gkekas, C., Gastounioti, A., Mantas, G., Nikita, K. S., Karakitsos, P., & Liapis, C. D. (2014) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.10.009 · Cited by 44
Tang, W., Huang, C., Tang, C., Xu, J., & Wang, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s94514 · Cited by 42
Beltrami, M., Ruocco, G. M., Dastidar, A. G., Franci, B., Lucani, B., Aloia, E., Nuti, R., & Palazzuoli, A. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.04.007 · Cited by 42
George, M., Shanmugam, E., Srivatsan, V., Vasanth, K., Ramraj, B., Rajaram, M., Jena, A., Sridhar, A., Chaudhury, M., & Ilango, K. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715578405 · Cited by 39
Coromilas, E. J., Que-Xu, E.-C., Moore, D., Kato, T., Wu, C. C. N., Ji, R., Givens, R. C., Jorde, U. P., Takayama, H., Naka, Y., et al. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0298-z · Cited by 37
Shimura, T., Shibata, M., Gonda, K., Nakajima, T., Chida, S., Noda, M., Suzuki, S., Nakamura, I., Ohki, S., & Takenoshita, S. (2016) · Biomedical Reports · doi:10.3892/br.2016.696 · Cited by 35
Tülüce, S. Y., Tülüce, K., Çil, Z., Emren, S. V., Akyıldız, Z. İ., & Ergene, O. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2015.6191 · Cited by 34
Yamaki, S., Fujii, T., Yajima, R., Hirakata, T., Yamaguchi, S., Fujisawa, T., Tsutsumi, S., Asao, T., Yanagita, Y., Iijima, M., et al. (2012) · Surgery Today · doi:10.1007/s00595-012-0378-3 · Cited by 33
Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis
Arangalage, D., Nguyen, V., Robert, T., Melissopoulou, M., Mathieu, T., Estellat, C., Codogno, I., Huart, V., Duval, X., Cimadevilla, C., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308873 · Cited by 33
A pilot study to demonstrate diagnostic potential of galectin-3 levels in saliva
Zhang, X., Wan, Y., Chata, R., Brazzale, A., Atherton, J. J., Kostner, K., Dimeski, G., & Punyadeera, C. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-203631 · Cited by 33
Yin, Q.-S., Shi, B., Dong, L., et al. (2014) · PubMed · doi:10.3969/j.issn.1671-5411.2014.01.014 · Cited by 32
Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites
McEvoy, J. W., Chen, Y., Halushka, M. K., Christenson, E. S., Ballantyne, C. M., Blumenthal, R. S., Christenson, R. H., & Selvin, E. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003079 · Cited by 32
Lee, Y. M., & Lee, J. B. (2013) · Journal of International Medical Research · doi:10.1177/0300060513477312 · Cited by 31
Bansal, N., Katz, R., Seliger, S. L., deFilippi, C. R., Sarnak, M. J., Delaney, J. A., Christenson, R. H., de Boer, I. H., Kestenbaum, B. R., Robinson‐Cohen, C., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.022 · Cited by 30
Edsfeldt, A., Bengtsson, E., Asciutto, G., Dunér, P., Björkbacka, H., Fredrikson, G. N., Nilsson, J. Å., & Gonçalves, I. (2016) · Cerebrovascular Diseases · doi:10.1159/000443022 · Cited by 30
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
von Klot, C. A., Kramer, M. W., Peters, I., Hennenlotter, J., Abbas, M., Scherer, R., Herrmann, T. R., Stenzl, A., Kuczyk, M. A., Serth, J., et al. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-15 · Cited by 29
Evaluation of galectin-3 levels in acute coronary syndrome
İpek, E. G., Suljevic, S. A., Kafes, H., Başyiğit, F., Karalok, N., Guray, Y. A., Asarcıklı, L. D., Açar, B., & Demirel, H. A. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.09.046 · Cited by 28
Perea, R. J., Morales‐Ruiz, M., Ortiz-Pérez, J. T., Bosch, X., Andreu, D., Borràs, R., Acosta, J., Penela, D., Prat, S., de Caralt, T. M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.070 · Cited by 27
Leal, M. F., Calcagno, D. Q., Chung, J., Freitas, V. M., Demachki, S., de Assumpção, P. P., Chammas, R. J., Burbano, R. M. R., & Smith, M. D. A. C. (2014) · Clinical and Experimental Medicine · doi:10.1007/s10238-014-0299-0 · Cited by 26
New onset atrial fibrillation is associated with elevated galectin-3 levels
Chen, D., Procter, N. E. K., Goh, V., Liu, S., Chua, S. J., Assadi-Khansari, B., Stewart, S., Horowitz, J. D., Sverdlov, A. L., & Ngo, D. T. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.172 · Cited by 26
Zhang, R., Zhang, Y., An, T., Guo, X., Yin, S., Wang, Y., Januzzi, J. L., Cappola, T. P., & Zhang, J. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.12 · Cited by 25
Prognostic value of plasma galectin‐3 levels after aneurysmal subarachnoid hemorrhage
Liu, H., Liu, Y., Zhao, J., Liu, H., & He, S. (2016) · Brain and Behavior · doi:10.1002/brb3.543 · Cited by 25
Ji, F., Zhang, S., Jiang, X., Xu, Y., Chen, Z., Fan, Y., & Wang, W. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22074 · Cited by 24
Gendy, H. E., Madkour, B., Abdelaty, S., Essawy, F., Khattab, D. W., Hammam, O., & Nour, H. (2014) · Current Urology · doi:10.1159/000365673 · Cited by 23
Feola, M., Testa, M., Leto, L., Cardone, M., Sola, M., & Rosso, G. L. (2016) · Medicine · doi:10.1097/md.0000000000004014 · Cited by 23
Issa, S. F., Christensen, A. F., Lottenburger, T., Junker, K., Lindegaard, H., Hørslev‐Petersen, K., & Junker, P. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12301 · Cited by 22
Galectin-3 as a new biomarker of diastolic dysfunction in hemodialysis patients
Gurel, O. M., Yılmaz, H., Çelik, T., et al. (2015) · Herz · doi:10.1007/s00059-015-4303-6 · Cited by 21
Zhou, K., Zhou, Y., Zhao, Y., Tan, C., Yuan, Z., Li, J., Liao, X., Gu, L., & Zhou, X. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.08.021 · Cited by 18
Serum Galectin-3: diagnostic value for papillary thyroid carcinoma
Yılmaz, E., Karşıdağ, T., Tatar, C., & Tüzün, S. (2015) · Turkish Journal of Surgery · doi:10.5152/ucd.2015.2928 · Cited by 17
Galectin 3 for the diagnosis of bladder cancer
Gendy, H. E., Madkour, B., Abdelaty, S., Essawy, F. M., Khattab, D., Hammam, O. A., Kholy, A. E., & Nour, H. H. (2013) · Arab Journal of Urology · doi:10.1016/j.aju.2013.10.004 · Cited by 15
Gao, N., Yu, W., Nong-jian, G., Wang, X., & Sun, J. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1243677 · Cited by 15
Yılmaz, H., Gurel, O. M., Celik, H. T., Bozkurt, A., Yildirim, M. E., Bilgiç, İ., Bilgiç, M. A., Bavbek, N., & Akçay, A. (2014) · Herz · doi:10.1007/s00059-014-4111-4 · Cited by 14
Can galectin‐3 be a useful marker for conventional papillary thyroid microcarcinoma?
Gweon, H. M., Kim, J., Youk, J. H., Hong, S. W., Lim, B. J., Yoon, S. O., Park, Y. M., & Son, E. J. (2015) · Diagnostic Cytopathology · doi:10.1002/dc.23408 · Cited by 13
Casanegra, A. I., Stoner, J. A., Tafur, A. J., Pereira, H. A., Rathbun, S. W., & Gardner, A. W. (2016) · Vascular Medicine · doi:10.1177/1358863x16644059 · Cited by 11
Lala, R. I., Dărăbanțiu, D., Pilat, L., & Pușchiță, M. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150149 · Cited by 10
Galectin-3 and prediction of therapeutic response to renal sympathetic denervation
Schwerg, M., Eilers, B., Wienecke, A., Baumann, G., Laule, M., Knebel, F., Stangl, K., & Stangl, V. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2016.1148157 · Cited by 8
Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients
Teixeira, A., Arrigo, M., Vergaro, G., Solal, A. C., & Mebazaa, A. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.08.010 · Cited by 5
Cited by
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
Current Advancements in Pectin: Extraction, Properties and Multifunctional Applications
Chandel, V., Biswas, D., Roy, S., Vaidya, D., Verma, A., & Gupta, A. (2022) · Foods · doi:10.3390/foods11172683 · Cited by 439
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Macrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
de Charette, M., & Houot, R. (2018) · Haematologica · doi:10.3324/haematol.2017.184192 · Cited by 129
Metadata
- Authors
- Dong, R., Zhang, M., Hu, Q., Zheng, S., Soh, A., Zheng, Y., & Yuan, H.
- Venue
- International Journal of Molecular Medicine
- Publisher
- Spandidos Publications
- Published
- 2017-12-05
- Volume
- 41
- Issue
- 2
- Pages
- 599-614
- ISSN
- 1107-3756 (ISSN-L)
- 1791-244X
- OpenAlex
- W2775139356
- Cited by
- 406
- References
- 102
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.